Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

A, Praha 4 N Clinical Trials

A listing of A, Praha 4 N clinical trials actively recruiting patients volunteers.

RESULTS

Found (7) clinical trials

If your Rheumatoid Arthritis is active and you are receiving Methotrexate, you may qualify to take part in this clinical research study. Contact us at Clinical Research of West Florida or visit us at TampaTrials.com.  

Phase N/A

A clinical research study of an investigational medication for SLE Lupus patients is being held in Tampa.  

Phase N/A

If you've had at least one flare-up in the last year, local doctors need your help with a research study testing an investigational medication. You will receive all study-related procedures at no cost if you qualify-and may be compensated for your time and travel. To learn more about this study: ...

Phase N/A

Local doctors are looking for people with Crohn's disease for clinical research studies of an investigational medication. Compensation provided for time and travel!  

Phase N/A

Are you a current or former smoker? Do you have trouble breathing or a persistent cough? If so, you may have a disease called Chronic Obstructive Pulmonary Disease or COPD. We are looking for people who are between 40 and 80 years old with COPD to participate in a clinical ...

Phase N/A

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

This is a multicenter, open-label, phase 1 study that is being done to test intratumoral injections of TTI-621 in patients that have relapsed and refractory percutaneously accessible solid tumors or mycosis fungoides. The study will be performed in two different parts: Dose Escalation and Dose Expansion. During the escalation part ...

Phase

A Phase 2 RCT Study of CX-8998 for Essential Tremor

This is a multicenter, double-blind, placebo-controlled, parallel-group study consisting of a screening period of up to 4 weeks (with the exception of subjects on primidone at baseline who will be allowed 6 weeks of screening to allow for safe discontinuation). Screening results from all patients meeting the eligibility requirements will ...

Phase